A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/222 (2006.01) A61K 31/351 (2006.01) A61P 9/06 (2006.01)
Patent
CA 2529367
The present invention relates to a novel method to prevent or attenuate atrial fibrillation (AF) promotion resulting from atrial tachycardia. In a study conducted with 39 dogs, the HMG-CoA reductase inhibitor simvastatin was found to significantly attenuate AF promotion. This finding constitutes the basis for an interesting new pharmaceutical approach for preventing the consequences of atrial tachycardia remodeling.
L'invention porte sur une nouvelle méthode de prévention ou atténuation de la promotion de la fibrillation auriculaire, à l'origine de la tachycardie auriculaire. Dans une étude effectuée sur 39 chiens, on a trouvé que la simvastatine, inhibiteur de la HMG-CoA réductase, atténuait significativement la promotion de ladite fibrillation. Cette découverte est la base d'une nouvelle approche pharmaceutique prévenant les conséquences d'un remodelage de la tachycardie auriculaire.
Institut de Cardiologie de Montreal/montreal Heart Institute
Tessier Louis
LandOfFree
Preventing atrial fibrillation (af) with the use of statin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventing atrial fibrillation (af) with the use of statin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing atrial fibrillation (af) with the use of statin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1792835